Chemicals

Myosin Kinase Inhibiting Peptide CAS NO.119386-39-9

<p>Myosin Kinase Inhibiting Peptide (CAS NO.: 119386-39-9), Formula: C40H78N18O11, MW: 987.2 g/mol is a highly specific bioactive peptide engineered to target and modulate myosin kinase pathways. Its precision in inhibiting kinase activity enables breakthrough applications in cellular motility research, muscular dystrophy studies, and oncology drug development.<br/></p>

SupplierGlobal Technology Co., Ltd.www.hqtechtirz.com
Source categories

About this product

Product information from the supplier.


TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
Myosin Kinase Inhibiting Peptide
CAS NO.
119386 - 39 - 9
Appearance
White to off-white lyophilized powder
Molecular Formula
C40H78N18O11
Molecular Weight
987.2 g/mol
Purity (RP-HPLC)
≥98%
Solubility

Soluble in water or phosphate - buffered 

Endotoxin≤1.0 EU/mg
Biological Activity
Myosin Kinase Inhibiting Peptide is a highly specific inhibitor of myosin kinase. In vitro studies have shown that it can effectively block the kinase activity, thereby interfering with the phosphorylation - mediated signaling pathways downstream of myosin kinase. This inhibition can lead to the modulation of muscle contraction, cell migration, and other cellular functions that are regulated by myosin kinase activity.
Storage Conditions
Stored at - 20°C in a dry environment.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

Targeted Kinase Inhibition: Binds directly to myosin kinase catalytic domains, blocking ATP binding and phosphorylation cascades.

Pathway Modulation: Disrupts downstream signaling responsible for actin-myosin contraction, cell migration, and proliferation.

    Reversible Dynamics: Exhibits dose-dependent inhibition with rapid reversibility upon washout, ideal for reversible cellular assays.


      2.PRODUCT INDICATIONS

      Muscle Physiology Research: Investigates excitation-contraction coupling in skeletal/cardiac muscles.
      Cancer Therapeutics: Evaluates anti-metastatic potential by inhibiting tumor cell motility.
      Neurodegenerative Studies: Examines microtubule dynamics in neuroblastoma and ALS models.
      Drug Screening: Serves as a reference compound for kinase inhibitor pipelines.


      3.CLINICAL EFFICACY OF PRODUCT

      In Vitro: Achieved 85% kinase inhibition (IC50: 50 nM) in HEK293 cells transfected with myosin kinase constructs.
      Ex Vivo: Reduced arterial smooth muscle contraction by 70% in rabbit aorta tissue assays.
      Oncology Models: Slowed metastasis in murine melanoma xenografts by 40% (p<0.01) when="" combined="" with="" chemotherapeutics="">.


      4.DELIVERY & SHIPPING

      We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
      Professional and Secure Packaging
      Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
      We can also customize packaging according to customer needs.
      Shipping Methods 
      Main Method: International Air Freight

      We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.